|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Current assets | ||||||||||
| Cash | ||||||||||
| Other receivable | ||||||||||
| Due from Sponsor | ||||||||||
| Cash and cash equivalents | ||||||||||
| Short-term investments | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Prepaid expenses | ||||||||||
| Total current assets | ||||||||||
| Deferred offering costs | ||||||||||
| Long-term prepaid insurance | ||||||||||
| Marketable securities held in Trust Account | ||||||||||
| Property and equipment, net | ||||||||||
| Long-term investments | ||||||||||
| Intangible assets, net | ||||||||||
| Operating lease right-of-use assets | ||||||||||
| Finance lease right-of-use assets | ||||||||||
| Other assets | ||||||||||
| Total Assets | ||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||
| Current liabilities | ||||||||||
| Accrued expenses | ||||||||||
| Accrued offering costs | ||||||||||
| Advance from related party | ||||||||||
| Promissory note - related party | ||||||||||
| Accounts payable and accrued expenses | ||||||||||
| Operating lease liabilities, current | ||||||||||
| Finance lease liabilities, current | ||||||||||
| Related party advance (Note 12) | ||||||||||
| Total current liabilities | ||||||||||
| Forward purchase agreement liability | ||||||||||
| Deferred underwriting fee | ||||||||||
| Deferred underwriting fee | ||||||||||
| Convertible notes, net of debt discount | ||||||||||
| Nonrelated party | ||||||||||
| Related party | ||||||||||
| Accrued interest on convertible notes | ||||||||||
| Nonrelated party | ||||||||||
| Related party | ||||||||||
| Operating lease liabilities, noncurrent | ||||||||||
| Finance lease liabilities, noncurrent | ||||||||||
| Deferred tax liabilities, net | ||||||||||
| Total liabilities | ||||||||||
| Class A ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of $10.55 and $10.23 per share at September 30, 2025 and December 31, 2024, respectively | ||||||||||
| Stockholders' Equity | ||||||||||
| Common shares, $0.0001 par value; 500,000,000 authorized shares; 82,718,567 and 81,771,422 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | ||||||||||
| Class B Ordinary Shares | ||||||||||
| Total common shares, $0.0001 par value; 500,000,000 authorized shares; 82,718,567 and 81,771,422 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | ||||||||||
| Exchangeable shares, $0.0001 par value; 23,216,687 and 24,011,017 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | ||||||||||
| Additional paid-in-capital | ||||||||||
| Accumulated deficit | ||||||||||
| Accumulated other comprehensive income | ||||||||||
| Total stockholders' equity | ||||||||||
| Total liabilities and stockholders' equity |
Loading...